Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia

Background: Standard of care (SoC) for transfusion-dependent β-thalassemia (TDT) requires lifelong, regular blood transfusions as well as chelation to reduce iron accumulation. Objective: This study investigates the cost-effectiveness of betibeglogene autotemcel (‘beti-cel’; LentiGlobin for β-thalas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kansal, Anuraag R., Reifsnider, Odette S., Brand, Sarah B., Hawkins, Neil, Coughlan, Anna, Li, Shujun, Cragin, Lael, Paramore, Clark, Dietz, Andrew C., Caro, J. Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205006/
https://www.ncbi.nlm.nih.gov/pubmed/34178295
http://dx.doi.org/10.1080/20016689.2021.1922028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205006/
https://www.ncbi.nlm.nih.gov/pubmed/34178295
http://dx.doi.org/10.1080/20016689.2021.1922028

Ejemplares similares